PropertyValue
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/ns/prov#value
  • other companies may receive approval for and market biosimilar or other products to compete with Aranesp?? in Europe, presenting additional competition, as further discussed below.
http://www.w3.org/ns/prov#wasQuotedFrom
  • marketplace.org